Docosahexaenoic Acid, Inflammation, and Bacterial Dysbiosis in Relation to Periodontal Disease, Inflammatory Bowel Disease, and the Metabolic Syndrome
Year: 2013
Type: review
Abstract: Docosahexaenoic acid (DHA), a long-chain omega-3 polyunsaturated fatty acid, has been used to treat a range of different conditions, including periodontal disease (PD) and inflammatory bowel disease (IBD). That DHA helps with these oral and gastrointestinal diseases in which inflammation and bacterial dysbiosis play key roles, raises the question of whether DHA may assist in the prevention or treatment of other inflammatory conditions, such as the metabolic syndrome, which have also been linked with inflammation and alterations in normal host microbial populations. Here we review established and investigated associations between DHA, PD, and IBD. We conclude that by beneficially altering cytokine production and macrophage recruitment, the composition of intestinal microbiota and intestinal integrity, lipopolysaccharide- and adipose-induced inflammation, and insulin signaling, DHA may be a key tool in the prevention of metabolic syndrome.
Source: Nutrients
DOI: 10.3390/nu5083299
Authors: Maria Tabbaa, Mladen Golubic, Michael Roizen, Adam Bernstein
Institution: Cleveland Clinic
Language: English
Subfield: Nutrition and Dietetics
Field: Nursing
Domain: Health Sciences
Keywords: docosahexaenoic acid, omega-3 polyunsaturated fatty acids, periodontal disease, inflammatory bowel disease, metabolic syndrome, inflammation, bacterial dysbiosis, gut microbiota, cytokine production, macrophage recruitment, intestinal integrity, lipopolysaccharide, adipose tissue inflammation, insulin signaling
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W1969193178
